Stock Movers
iHeartPodcasts
Listen for five-minute conversations on today's biggest winners and losers in the stock market.
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.
Episodes
Mentioned books
Apr 1, 2026 • 5min
Rolls-Royce Gains, Lufthansa Rises, Berkeley Tumbles
Tiwa Adebayo, Bloomberg reporter covering markets and companies, breaks down big movers. Rolls‑Royce jumps on defense and energy interest. Airlines navigate Middle East risks and contingency planning. UK housebuilder Berkeley tumbles after sharply cut profit outlook tied to regional uncertainty.
Apr 1, 2026 • 5min
Shell Dips, Lufthansa Rises, Berkeley Tumbles
Chloe Malay, a Bloomberg reporter covering European equities and energy, aviation and housing moves. She outlines how energy market swings nudged Shell lower. She explains why airlines like Lufthansa rose amid easing fuel fears and contingency planning. She also covers why Berkeley plunged after warning of weaker medium‑term earnings tied to geopolitical and rate risks.
Mar 31, 2026 • 3min
Nike Slips, Airlines Surge, Apellis Pharma Soars
Avalon Pernell, a Bloomberg equities reporter covering markets and company moves. She discusses why Nike slid despite stronger sales, the surprise rally across airlines as fuel and geopolitical worries shift, and Biogen’s $5.6B takeover of Apellis that sent the biotech’s stock soaring.
Mar 31, 2026 • 5min
Closing Bell: Marvell Surges on Nvidia Deal, Delta Rises, McCormick Sinks
Big tech ties shift chipmaking: a $2B investment sparks a silicon photonics collaboration aimed at speeding AI data transfer. Airlines upgrade onboard connectivity by adopting a satellite internet service for hundreds of planes. A major food maker agrees to combine businesses in a sizable deal, while energy stocks show unexpected weakness amid broader market strength.
Mar 31, 2026 • 4min
Constellation Energy Drops, Marvell Rallies on Nvidia Investment, Unilever Slides
Nora Melinda, a Bloomberg Television markets correspondent, breaks down big market movers. She covers Constellation Energy’s EPS guidance miss and lack of data-center detail. She discusses Nvidia’s $2B stake in Marvell and their silicon photonics and AI networking tie-up. She reviews Unilever’s controversial $44.8B food deal with McCormick and the market reaction.
Mar 31, 2026 • 2min
Constellation Energy Falls, McCormick Slides, Apellis Pharmaceuticals Gains
A rundown of heavy market moves in energy, consumer goods and biotech. Discussion of an energy company’s earnings forecast miss and its stock drop. Coverage of a major food-business merger that rattled a seasoning maker’s shares. Report on a biotech takeover that sent its stock sharply higher.
Mar 31, 2026 • 4min
Eli Lilly Gains, McCormick Rises, Allbirds Soars on American Exchange Deal
Valdana Hyrik, a market analyst who summarizes fast-moving equity news. She breaks down Eli Lilly’s big buy to broaden its pipeline. She outlines the McCormick-Unilever food combination and its market implications. She covers Allbirds’ asset sale and the brand’s rise and decline.
Mar 31, 2026 • 4min
Biogen to Buy Apellis; Lilly to Buy Sleep Drug Maker; Nvidia Invests $2 Billion in Marvell
Big biotech deals take center stage as one company agrees to a $5.6B takeover to broaden its immunology and rare-disease portfolio. A major pharma makes a multi-billion bid for a sleep-drug developer to diversify beyond weight-loss treatments. A tech giant pours $2B into a chip maker to accelerate silicon photonics for more affordable AI infrastructure.
Mar 31, 2026 • 4min
Lilly to Buy Centessa Pharmaceuticals; Biogen to Buy Apellis; Unilever Foods Exit
Big pharma takeover targets and deal mechanics dominate the conversation. Major buyouts in biotech and pharma reshuffle pipelines and market positions. A historic consumer-food divestment and complex cash-and-equity terms get detailed attention. A clinical trial disappointment and its stock fallout round out the market-moving headlines.
Mar 31, 2026 • 4min
LVMH Falls, Future Slumps, Dermapharm Drops
Tua Adebayo, a reporter who covers European stock movers, walks through major market shifts. She highlights how LVMH, SAP and Novo Nordisk drove big Stoxx 600 losses. She breaks down Future PLC’s weak trading update, ad and e-commerce pressures, and margin worries. She also covers Dermapharm’s results and the market reaction.
